Accuracy and reliability of continuous blood glucose monitoring during pediatric cardiopulmonary bypass

Kawahito, Shinji; Mita, Naoji; Soga, Tomohiro; Yagi, Shusuke; Kakuta, Nami; Satomi, Shiho; Kinoshita, Hiroyuki; Takaishi, Kazumi; Kitagawa, Tetsuya; Kitahata, Hiroshi

doi:10.1007/s10047-019-01111-9

Cited by 2 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several current studies 19‐21 in cardiac surgery supported this report 22 that perioperative strict glycemic control, such as IIT, using an AP might be effective and safe not only in the prevention of hypoglycemia, hyperglycemia, and variability of blood glucose range, but also in the reduction of postoperative inflammation.…”

Section: Current Bedside Ap Stg‐55 With Closed‐loop Systemsupporting

confidence: 60%

“…A good indication of perioperative glycemic control using bedside AP is shown in Table 1. Gastroenterological surgery, [14][15][16][17] cardiovascular surgery, [19][20][21][22][23] and transplantation [24][25][26] are likely to cause surgical stress-induced hyperglycemia, leading to infectious complications causing poor surgical outcomes. Moreover, other specific diseases and/or cases with diabetes, glucose intolerance, and uncontrolled glycemic administration due to conventional glycemic control methods, such as the sliding-scale method and bolus injection insulin therapy (Table 1), contribute to poor surgical outcomes.…”

Section: Perioperative Strict Glycemic Control Using Apmentioning

confidence: 99%

See 1 more Smart Citation

Closed‐loop artificial endocrine pancreas from Japan

et al. 2021

View full text Add to dashboard Cite

The development of a closed‐loop artificial pancreas (AP) in the Western countries and Japan is different. In Western countries, wearable AP with a closed‐loop glycemic control system has been developed as a treatment for patients with type 1 and type 2 diabetes. On the contrary, in Japan, bedside closed‐loop AP explored by a Japanese company (Nikkiso, Tokyo, Japan) has developed as perioperative glycemic control device in surgical patients and acute care patients with emergency. In this article, we reviewed the scientific evidence in the past and present and future prospects of perioperative glycemic control using bedside AP with a closed‐loop system in Japan. Conventional perioperative strict glycemic controls have three major problems: hyperglycemia, hypoglycemia, and variability in blood glucose concentrations. In Japan, perioperative strict glycemic control using the current bedside AP STG‐55 (Nikkiso, Tokyo, Japan) has been developed since 2010. This novel glycemic control method achieved not only stable glycemic control without hyperglycemia, hypoglycemia, and less variability of blood glucose concentrations but also reduced postoperative infectious complications in patients undergoing major surgeries. Among the rapidly increasing number of surgical or emergency patients with diabetes, frailty, and sarcopenia of intrinsic glucose intolerance, more sophisticated and smaller AP available easily in operating rooms and intensive care units will be warranted to promote improved therapeutic outcomes in such critically ill patients.

show abstract

Section: Current Bedside Ap Stg‐55 With Closed‐loop Systemsupporting

confidence: 60%

Section: Perioperative Strict Glycemic Control Using Apmentioning

confidence: 99%

Closed‐loop artificial endocrine pancreas from Japan

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Using a continuous blood glucose monitoring and control system (artificial pancreas : STG-55 from Nikkiso Corporation), studies have performed blood glucose control during CPB (Fig. 6) (38)(39)(40). The blood glucose level suddenly showed an upward trend after the start of CPB, but was controlled to around 150 mg / dL through appropriate insulin administration.…”

Section: Hyperglycemiamentioning

confidence: 99%

Pathophysiology and Complications during Extracorporeal Circulation

et al. 2020

Self Cite

View full text Add to dashboard Cite

Extracorporeal circulation, unlike pulsatile flow based on the beating heart, is the non-pulsatile flow through a blood pump, and the systemic circulation falls into non-physiological conditions. The living body shows various reactions to extracorporeal circulation. The pathophysiology of extracorporeal circulation includes changes in hemodynamics, coagulation, fibrinolysis, acid-base equilibrium, electrolytes, incretion, metabolism, and immune system. With advances in extracorporeal circulation technology, operability has been dramatically improved and safety has rapidly advanced as well. However, there are specific complications with extracorporeal circulation. We need to have a good knowledge of the pathophysiology and complications during extracorporeal circulation, as well as each component of the extracorporeal circulation system.

show abstract

Accuracy and reliability of continuous blood glucose monitoring during pediatric cardiopulmonary bypass

Cited by 2 publications

References 13 publications

Closed‐loop artificial endocrine pancreas from Japan

Closed‐loop artificial endocrine pancreas from Japan

Pathophysiology and Complications during Extracorporeal Circulation

Contact Info

Product

Resources

About